MA30394B1 - Synthese d'acylaminoalcenylene-amides pouvant etre employes en tant qu'antagonistes de la substance p - Google Patents
Synthese d'acylaminoalcenylene-amides pouvant etre employes en tant qu'antagonistes de la substance pInfo
- Publication number
- MA30394B1 MA30394B1 MA31347A MA31347A MA30394B1 MA 30394 B1 MA30394 B1 MA 30394B1 MA 31347 A MA31347 A MA 31347A MA 31347 A MA31347 A MA 31347A MA 30394 B1 MA30394 B1 MA 30394B1
- Authority
- MA
- Morocco
- Prior art keywords
- synthesis
- substance
- acylaminoalcenylene
- agonists
- amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRÉSENTE INVENTION CONCERNE UN PROCÉDÉ DE SYNTHÈSE DE COMPOSÉS DE FORMULE (I) OU DE SOLVATES OU HYDRATES DESDITS COMPOSÉS, R, R1, R2, R3 ET R5 AYANT LES VALEURS DÉFINIES DANS LA DESCRIPTION DE L'INVENTION. DE TELS COMPOSÉS PEUVENT ÊTRE EMPLOYÉS DANS LE TRAITEMENT DE PLUSIEURS ÉTATS PATHOLOGIQUES ASSOCIÉS À LA SUBSTANCE P ET À LA NEUROKININE.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0607532A GB0607532D0 (en) | 2006-04-13 | 2006-04-13 | Organic compounds |
| GB0610244A GB0610244D0 (en) | 2006-05-23 | 2006-05-23 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA30394B1 true MA30394B1 (fr) | 2009-05-04 |
Family
ID=38324102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA31347A MA30394B1 (fr) | 2006-04-13 | 2008-11-03 | Synthese d'acylaminoalcenylene-amides pouvant etre employes en tant qu'antagonistes de la substance p |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US8008479B2 (fr) |
| EP (1) | EP2010498B1 (fr) |
| JP (1) | JP5208917B2 (fr) |
| KR (1) | KR20080108291A (fr) |
| AR (1) | AR060506A1 (fr) |
| AT (1) | ATE486853T1 (fr) |
| AU (1) | AU2007237482B2 (fr) |
| CA (1) | CA2645362C (fr) |
| CL (1) | CL2007001040A1 (fr) |
| CY (1) | CY1111294T1 (fr) |
| DE (1) | DE602007010269D1 (fr) |
| DK (1) | DK2010498T3 (fr) |
| EC (1) | ECSP088820A (fr) |
| GT (1) | GT200800209A (fr) |
| HK (1) | HK1125640A1 (fr) |
| HR (1) | HRP20110045T1 (fr) |
| JO (1) | JO2630B1 (fr) |
| MA (1) | MA30394B1 (fr) |
| MX (1) | MX2008013117A (fr) |
| MY (1) | MY145069A (fr) |
| NO (1) | NO20084783L (fr) |
| NZ (1) | NZ571142A (fr) |
| PE (1) | PE20071223A1 (fr) |
| PL (1) | PL2010498T3 (fr) |
| PT (1) | PT2010498E (fr) |
| RU (1) | RU2433122C2 (fr) |
| SI (1) | SI2010498T1 (fr) |
| TW (1) | TW200815358A (fr) |
| WO (1) | WO2007118651A1 (fr) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007004261A (es) | 2004-10-12 | 2007-06-18 | Fmc Biopolymer As | Sistemas de alginato auto-gelificantes y usos de los mismos. |
| CN101273024A (zh) | 2005-07-29 | 2008-09-24 | 康瑟特制药公司 | 新颖苯并[d][1,3]-二氧杂环戊烯衍生物 |
| US8796267B2 (en) | 2006-10-23 | 2014-08-05 | Concert Pharmaceuticals, Inc. | Oxazolidinone derivatives and methods of use |
| US8080549B2 (en) | 2007-01-12 | 2011-12-20 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
| US8071596B2 (en) | 2007-01-12 | 2011-12-06 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
| US8013007B2 (en) | 2007-02-26 | 2011-09-06 | Concert Pharmaceuticals, Inc. | Alpha 1A-adrenoceptor antagonists |
| JP2010520291A (ja) | 2007-03-07 | 2010-06-10 | コンサート ファーマシューティカルズ インコーポレイテッド | 抗狭心症化合物としての重水素化ピペラジン誘導体 |
| WO2008115442A1 (fr) | 2007-03-16 | 2008-09-25 | Concert Pharmceuticals, Inc. | Inhibiteurs de protéine de transfert d'ester de cholestérol |
| WO2008128166A1 (fr) | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Dérivés deutériés de composés 4-(6-fluoro-1,2-benzisoxazol-3-yl) pipéridine |
| WO2008133949A1 (fr) | 2007-04-25 | 2008-11-06 | Concert Pharmaceuticals, Inc. | Analogues de cilostazol |
| US8349817B2 (en) | 2007-04-25 | 2013-01-08 | Concert Pharmaceuticals, Inc. | Analogues of cilostazol |
| PL2357183T3 (pl) | 2007-05-01 | 2015-12-31 | Concert Pharmaceuticals Inc | Związki morfinanu |
| MX2009011958A (es) | 2007-05-01 | 2010-06-30 | Concert Pharmaceuticals Inc | Compuestos de morfina. |
| US7820666B2 (en) | 2007-05-08 | 2010-10-26 | Concert Pharmaceuticals, Inc. | Tetrahydrotriazolopyrazine derivatives and uses thereof |
| SI2003120T1 (sl) | 2007-06-12 | 2010-03-31 | Concert Pharmaceuticals Inc | Azapeptidni derivati kot inhibitorji hiv proteaze |
| US7687509B2 (en) | 2007-07-09 | 2010-03-30 | Concert Pharmaceuticals Inc. | Pyrimidinecarboxamide derivatives |
| ES2425183T3 (es) | 2007-08-14 | 2013-10-11 | Concert Pharmaceuticals Inc. | Derivados de oxazolidinonas sustituidas |
| AU2008296975B2 (en) | 2007-08-28 | 2014-07-24 | Fmc Corporation | Delayed self-gelling alginate systems and uses thereof |
| US7994194B2 (en) | 2007-09-12 | 2011-08-09 | Concert Pharmaceuticals, Inc. | 4-oxoquinoline derivatives |
| US8822498B2 (en) | 2007-09-13 | 2014-09-02 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof |
| WO2009051782A1 (fr) | 2007-10-18 | 2009-04-23 | Concert Pharmaceuticals Inc. | Étravirine deutérée |
| US8592487B2 (en) | 2007-10-26 | 2013-11-26 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
| US8084464B2 (en) | 2007-12-18 | 2011-12-27 | Concert Pharmaceuticals, Inc. | Tetrahydroisoquinoline derivatives |
| US8609673B2 (en) | 2008-01-22 | 2013-12-17 | Concert Pharmaceuticals, Inc. | Vandetanib derivatives |
| EP2242493B1 (fr) | 2008-01-22 | 2013-06-05 | Concert Pharmaceuticals Inc. | Dérivés de géfitinib |
| BRPI0908107A2 (pt) | 2008-02-29 | 2019-09-24 | Concert Pharmaceuticals Inc | composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente |
| WO2009128947A1 (fr) | 2008-04-17 | 2009-10-22 | Concert Pharmaceuticals, Inc. | Dérivés de pipérazine |
| US8354557B2 (en) | 2008-06-17 | 2013-01-15 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated morpholine derivatives |
| CN102176826B (zh) | 2008-08-29 | 2014-08-20 | 康瑟特制药公司 | 取代的三唑并哒嗪衍生物 |
| WO2010033511A1 (fr) | 2008-09-16 | 2010-03-25 | Concert Pharmaceuticals, Inc. | Dérivés d’acide 2-amino-3-hydroxypropanoïque deutérés |
| ES2656444T3 (es) | 2008-09-19 | 2018-02-27 | Concert Pharmaceuticals, Inc. | Compuestos de morfinano deuterados |
| US9045453B2 (en) | 2008-11-14 | 2015-06-02 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
| AU2010217615C1 (en) * | 2009-02-24 | 2013-05-23 | Novartis Ag | Uses of NK receptor antagonists |
| US8263601B2 (en) | 2009-02-27 | 2012-09-11 | Concert Pharmaceuticals, Inc. | Deuterium substituted xanthine derivatives |
| DE102009001446A1 (de) | 2009-03-10 | 2010-09-23 | Evonik Rohmax Additives Gmbh | Verwendung von Kammpolymeren als Antifatigue-Additive |
| US8563554B2 (en) | 2009-03-17 | 2013-10-22 | Concert Pharmaceuticals, Inc. | Deuterated pyrazinoisoquinoline compounds |
| WO2010108103A1 (fr) * | 2009-03-19 | 2010-09-23 | Concert Pharmaceuticals, Inc. | Dérivés d'azépan-2-one |
| WO2010124046A1 (fr) | 2009-04-23 | 2010-10-28 | Concert Pharmaceuticals, Inc. | Analogues de l'acide 4-hydroxybutyrique |
| US8410082B2 (en) | 2009-05-22 | 2013-04-02 | Concert Pharmaceuticals, Inc. | Fluorinated diaryl urea derivatives |
| ES2469849T3 (es) | 2009-06-18 | 2014-06-20 | Concert Pharmaceuticals Inc. | Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa |
| WO2011005520A1 (fr) | 2009-06-23 | 2011-01-13 | Concert Pharmaceuticals, Inc. | Dérivés de triazolo-pyridazine modifiés par deutérium comme modulateurs du récepteur gabaa |
| EP2464355A4 (fr) | 2009-08-14 | 2013-01-02 | Concert Pharmaceuticals Inc | Dérivés de triazolophtalazine substituée |
| CA2771331A1 (fr) | 2009-09-02 | 2011-03-10 | Concert Pharmaceuticals, Inc. | Derives de xanthine substitues |
| US9260432B2 (en) | 2009-09-02 | 2016-02-16 | Concert Pharmaceuticals, Inc. | Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds |
| WO2011047315A1 (fr) | 2009-10-15 | 2011-04-21 | Concert Pharmaceuticals, Inc. | Benzimidazoles substitués |
| WO2011063001A1 (fr) | 2009-11-18 | 2011-05-26 | Concert Pharmaceuticals, Inc. | Promédicaments de niacine et versions deutérisées de ceux-ci |
| DE102010001040A1 (de) | 2010-01-20 | 2011-07-21 | Evonik RohMax Additives GmbH, 64293 | (Meth)acrylat-Polymere zur Verbesserung des Viskositätsindexes |
| US8575361B2 (en) | 2010-03-02 | 2013-11-05 | Concert Pharmaceuticals Inc. | Tetrahydronaphthalene derivatives |
| EP3144296A1 (fr) | 2010-03-02 | 2017-03-22 | Concert Pharmaceuticals, Inc. | Dérivés de tétrahydronaphtalène deutéré |
| US9226801B2 (en) * | 2010-03-08 | 2016-01-05 | Ibur, Llc | Custom linkable imaging and multifunctional tray |
| WO2011116066A1 (fr) | 2010-03-17 | 2011-09-22 | Concert Pharmaceuticals, Inc. | Dérivés de diméthylcurcumine |
| WO2012009446A1 (fr) | 2010-07-16 | 2012-01-19 | Concert Pharmaceuticals Inc. | Nouveaux dérivés pyrimidinecarboxamide |
| WO2012031073A1 (fr) | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Procédé de préparation d'un alcool secondaire deutéré à enrichissement énantiomérique à partir d'une cétone correspondante sans réduction de l'intégration de deutérium |
| US9085788B2 (en) | 2010-09-01 | 2015-07-21 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
| MX355742B (es) | 2011-02-14 | 2018-04-26 | Concert Pharmaceuticals Inc | Análogos deuterados del ácido 4-hidroxibutírico. |
| US9145390B2 (en) | 2011-03-03 | 2015-09-29 | Concert Pharmaceuticals, Inc. | Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| WO2012122028A2 (fr) | 2011-03-04 | 2012-09-13 | Concert Pharmaceuticals Inc. | Composés de pyrazino-isoquinoline |
| HUE047354T2 (hu) | 2011-05-18 | 2020-04-28 | Vertex Pharmaceuticals Europe Ltd | Ivacaftor deuterizált származékai |
| WO2013155465A1 (fr) | 2012-04-13 | 2013-10-17 | Concert Pharmaceuticals, Inc. | Dérivés de xanthine substituée |
| WO2013159026A1 (fr) | 2012-04-20 | 2013-10-24 | Concert Pharmaceuticals, Inc. | Rigosertib deutéré |
| US20150197525A1 (en) | 2012-06-15 | 2015-07-16 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of ruxolitinib |
| US9181190B2 (en) | 2012-07-04 | 2015-11-10 | Concert Pharmaceuticals, Inc. | Deuterated vercirnon |
| US10017445B2 (en) | 2012-07-12 | 2018-07-10 | Concert Pharmaceuticals, Inc. | Deuterated idebenone |
| EA201590296A1 (ru) | 2012-07-30 | 2015-07-30 | Консерт Фармасьютикалс Инк. | Дейтерированный ибрутиниб |
| AU2013302519B2 (en) | 2012-08-17 | 2017-11-02 | Concert Pharmaceuticals, Inc. | Deuterated baricitinib |
| US9643950B2 (en) | 2012-10-22 | 2017-05-09 | Concert Pharmaceuticals, Inc. | Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione} |
| MX2015008829A (es) | 2013-01-09 | 2016-04-25 | Concert Pharmaceuticals Inc | Momelotinib deuterado. |
| AU2014237569B2 (en) | 2013-03-15 | 2019-03-14 | Concert Pharmaceuticals Inc. | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase |
| US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| WO2015031741A1 (fr) | 2013-08-30 | 2015-03-05 | Concert Pharmaceuticals, Inc. | Thiénotriazolodiazépines substituées |
| WO2015120393A1 (fr) | 2014-02-10 | 2015-08-13 | Concert Pharmaceuticals, Inc. | Triazolobenzodiazépines substituées |
| EP3212656B1 (fr) | 2014-10-27 | 2019-06-05 | Concert Pharmaceuticals Inc. | Esters d'acide phosphonique de pyrimidine portant au moins un atome de deutérium |
| EP3277647A1 (fr) | 2015-03-31 | 2018-02-07 | Vertex Pharmaceuticals (Europe) Limited | Vx-661 deutéré |
| US10683305B2 (en) | 2015-04-27 | 2020-06-16 | Concert Pharmaceuticals, Inc. | Deuterated OTX-015 |
| US10759721B2 (en) | 2015-09-25 | 2020-09-01 | Vertex Pharmaceuticals (Europe) Limited | Deuterated CFTR potentiators |
| US11267777B2 (en) | 2015-11-19 | 2022-03-08 | Concert Pharmaceuticals, Inc. | Deuterated EPI-743 |
| WO2017143038A1 (fr) | 2016-02-16 | 2017-08-24 | Concert Pharmaceuticals, Inc. | Gft-505 deutéré |
| EP3713557A1 (fr) | 2017-11-22 | 2020-09-30 | Concert Pharmaceuticals Inc. | Analogues deutérés de d-sérine et leurs utilisations |
| CN117924170A (zh) | 2017-12-01 | 2024-04-26 | 弗特克斯药品有限公司 | 用于制备囊性纤维化跨膜传导调节因子的调节剂的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100389253B1 (ko) | 1995-02-22 | 2003-08-19 | 노파르티스 아게 | 1-아릴-2-아실아미노-에탄화합물및뉴로키닌,특히뉴로키닌1길항제로서의그의용도 |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB0010958D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
-
2007
- 2007-04-10 JO JO2007129A patent/JO2630B1/en active
- 2007-04-11 CA CA2645362A patent/CA2645362C/fr not_active Expired - Fee Related
- 2007-04-11 KR KR1020087024839A patent/KR20080108291A/ko not_active Application Discontinuation
- 2007-04-11 RU RU2008145102/04A patent/RU2433122C2/ru not_active IP Right Cessation
- 2007-04-11 DE DE602007010269T patent/DE602007010269D1/de active Active
- 2007-04-11 AT AT07724154T patent/ATE486853T1/de active
- 2007-04-11 JP JP2009504637A patent/JP5208917B2/ja not_active Expired - Fee Related
- 2007-04-11 AR ARP070101533A patent/AR060506A1/es not_active Application Discontinuation
- 2007-04-11 WO PCT/EP2007/003213 patent/WO2007118651A1/fr active Application Filing
- 2007-04-11 AU AU2007237482A patent/AU2007237482B2/en not_active Ceased
- 2007-04-11 PE PE2007000444A patent/PE20071223A1/es not_active Application Discontinuation
- 2007-04-11 US US12/296,969 patent/US8008479B2/en not_active Expired - Fee Related
- 2007-04-11 PT PT07724154T patent/PT2010498E/pt unknown
- 2007-04-11 NZ NZ571142A patent/NZ571142A/en not_active IP Right Cessation
- 2007-04-11 DK DK07724154.5T patent/DK2010498T3/da active
- 2007-04-11 SI SI200730483T patent/SI2010498T1/sl unknown
- 2007-04-11 MX MX2008013117A patent/MX2008013117A/es active IP Right Grant
- 2007-04-11 PL PL07724154T patent/PL2010498T3/pl unknown
- 2007-04-11 EP EP07724154A patent/EP2010498B1/fr active Active
- 2007-04-12 TW TW096112886A patent/TW200815358A/zh unknown
- 2007-04-12 CL CL200701040A patent/CL2007001040A1/es unknown
-
2008
- 2008-10-08 MY MYPI20083997A patent/MY145069A/en unknown
- 2008-10-10 GT GT200800209A patent/GT200800209A/es unknown
- 2008-10-13 EC EC2008008820A patent/ECSP088820A/es unknown
- 2008-11-03 MA MA31347A patent/MA30394B1/fr unknown
- 2008-11-12 NO NO20084783A patent/NO20084783L/no not_active Application Discontinuation
-
2009
- 2009-05-15 HK HK09104457.9A patent/HK1125640A1/xx not_active IP Right Cessation
-
2011
- 2011-01-21 HR HR20110045T patent/HRP20110045T1/hr unknown
- 2011-01-26 CY CY20111100082T patent/CY1111294T1/el unknown
- 2011-07-22 US US13/188,795 patent/US20110282053A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA30394B1 (fr) | Synthese d'acylaminoalcenylene-amides pouvant etre employes en tant qu'antagonistes de la substance p | |
| MA30638B1 (fr) | Composes organiques | |
| MA31373B1 (fr) | Composes amino-heterocycliques | |
| MA30911B1 (fr) | Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine | |
| MA30912B1 (fr) | Nouveaux derives de phenylsulfamoyl-benzamide en tant qu'antagonistes de la bradykinine | |
| TN2009000138A1 (fr) | Biaryl-ether-urees | |
| MA30916B1 (fr) | Nouveaux derives de benzamide en tant qu'antagonistes de bradykinine | |
| MA29311B1 (fr) | Derives d'isoxazolines et son nouveau procede de production | |
| MA31597B1 (fr) | Nouveaux herbicides | |
| TNSN02012A1 (fr) | Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant | |
| DE60131967D1 (de) | Nr1h4-kern-rezeptor-bindende verbindungen | |
| ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
| MA32407B1 (fr) | Sels et polymorphes d'un composé tétracycline | |
| ATE524433T1 (de) | Trpv1 agonisten , zubereitungen die diese enthalten und ihre anwendung | |
| MA29870B1 (fr) | Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs | |
| SE0301368D0 (sv) | Chemical compounds | |
| TN2011000252A1 (fr) | Lactames servant d'inhibiteurs de beta-secretase | |
| TN2010000173A1 (fr) | Antagonistes de cgrp | |
| MA31742B1 (fr) | Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique | |
| BRPI0409069A (pt) | compostos quìmicos | |
| NO20092076L (no) | Ny fremgangsmate for fremstilling av 4,4'-(1-metyl-1,2-etandiyl)-bis-(2,6-piperazindion) | |
| MA29248B1 (fr) | Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation | |
| MA31252B1 (fr) | Macrolides a base d'erythromycine | |
| UA84020C2 (ru) | Ингибитор проникновения вируса вил | |
| ATE460425T1 (de) | Histondeacetylaseinhibitor und verfahren zu dessen herstellung |